TD Asset Management’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-71,200
Closed -$480K 1448
2023
Q3
$480K Sell
71,200
-1,000
-1% -$8.19K ﹤0.01% 1287
2023
Q2
$708K Buy
+72,200
New +$733K ﹤0.01% 1197
2021
Q3
Sell
-33,716
Closed -$234K 1558
2021
Q2
$234K Buy
33,716
+2,160
+7% +$18.7K ﹤0.01% 1470
2021
Q1
$321K Buy
31,556
+2,245
+8% +$21.1K ﹤0.01% 1443
2020
Q4
$229K Buy
29,311
+1,478
+5% +$13K ﹤0.01% 1415
2020
Q3
$241K Buy
27,833
+3,798
+16% +$38.3K ﹤0.01% 1325
2020
Q2
$230K Buy
+24,035
New +$187K ﹤0.01% 1279

Other funds holding VMD

TD Asset Management's VMD Position: Q4 2023 in Review

TD Asset Management sold out of Viemed Healthcare (VMD) in Q4 2023, closing a stake of 71,200 shares — an estimated $480K sold.

TD Asset Management first reported a position in VMD in Q2 2020 and held it in 7 quarters. The position peaked at $708K in Q2 2023. 104 funds tracked by Wall St. Rank hold VMD as of Q4 2023.

  • TD Asset Management reported no remaining Viemed Healthcare position as of Q4 2023 after selling out during the quarter.
  • TD Asset Management sold 71,200 Viemed Healthcare shares in Q4 2023, an estimated $480K.
  • TD Asset Management first reported a position in Viemed Healthcare in Q2 2020 and held it in 7 quarters.
  • TD Asset Management's Viemed Healthcare position peaked at $708K in Q2 2023.
  • 104 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2023.

Based on TD Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.